ReviewCNS neuroscience & therapeutics2026
Oxygen Therapy for Intracranial Hemorrhage.
Review in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hyperbaric Oxygen Therapy for Cognitive Impairment Resulting from Neurological Disorders: Mechanisms of Action and Application Advances.International journal of medical sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
aimsIntracranial hemorrhage (ICH) is a severe cerebrovascular disease with a high mortality rate that impairs patient well-being and quality of life. Oxygen therapies, including hyperbaric hyperoxia (HBO) and normobaric hyperoxia (NBO), have attracted widespread attention as potential adjuvant treatments because of their neuroprotective effects. This review aimed to summarize the current literature addressing the neuroprotective mechanisms of oxygen therapy in ICH, as well as its effectiveness and safety in patients with ICH.
methodsWe systematically searched multiple literature databases including PubMed, Embase, and Cochrane for publications containing specified keywords and published prior to November 2025. The references were thoroughly reviewed to identify other articles that may have been missed in our search.
resultsA total of 38 articles were included in this study. Among them, 20 mainly studied the mechanism of oxygen therapy after ICH, eight mainly investigated the effects of oxygen therapy in patients with ICH, and 10 primarily analyzed the safety of oxygen therapy in patients with ICH. The experimental results showed that the treatment mechanism of HBO mainly involves reducing cerebral vasospasm, promoting angiogenesis, inhibiting inflammatory responses, and improving aerobic energy metabolism, whereas NBO mainly protects the blood-brain barrier (BBB), reduces cerebral edema and hemispheric swelling, mitigates acute inflammation, inhibits oxidative stress and neuronal cell death, and enhances aerobic metabolism. Clinical trials have shown that oxygen therapy can improve neurological function recovery and long-term prognosis in patients with ICH, as reflected by better scores in some indicators and lower mortality rates; however, oxygen therapy also has controversial and potential risks. Excessive oxygen supply may lead to adverse reactions, and hyperoxia may negatively impact patients with ICH. An appropriate treatment plan should be formulated for the clinical application of oxygen therapy.
conclusionOxygen therapy shows potential in ICH treatment through multiple mechanisms; however, its safety and optimal regimen require further large-scale randomized controlled trials to balance the benefits and risks and optimize its application strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.